Author: Atak, Mehmet Fatih; Farabi, Banu; Akbayrak, Atiye; KalelioÄŸlu, Mehmet Berati; Rao, Babar K.
Title: Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVIDâ€19 without hydroxychloroquine use: Report of the first case Cord-id: m721p0td Document date: 2021_6_27
ID: m721p0td
Snippet: Favipiravir is an antiviral agent used in the treatment of COVID-19 infection, and related cutaneous adverse events are rare 1 . Acute generalized exanthematous pustulosis (AGEP) has been reported in COVID-19 patients, mostly associated with hydroxychloroquine (HCQ). There are few AGEP cases in COVID-19 patients reported due to β-lactam antibiotics 2,3 in the literature. Herein, we report the first case of favipiravir-induced AGEP with histologic findings.
Document: Favipiravir is an antiviral agent used in the treatment of COVID-19 infection, and related cutaneous adverse events are rare 1 . Acute generalized exanthematous pustulosis (AGEP) has been reported in COVID-19 patients, mostly associated with hydroxychloroquine (HCQ). There are few AGEP cases in COVID-19 patients reported due to β-lactam antibiotics 2,3 in the literature. Herein, we report the first case of favipiravir-induced AGEP with histologic findings.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date